Progyny, Inc.
$18.64
▼
-1.54%
2026-04-21 08:49:01
www.progyny.com
NMS: PGNY
Explore Progyny, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$1.42 B
Current Price
$18.64
52W High / Low
$28.75 / $16.1
Stock P/E
24.25
Book Value
$6.24
Dividend Yield
—
ROCE
15.79%
ROE
12.48%
Face Value
—
EPS
$0.65
Exp Qtr EPS
—
Sector
Healthcare
Industry
Healthcare Plans
Employees
835
Beta
0.99
Debt / Equity
5.37
Current Ratio
2.73
Quick Ratio
2.73
Forward P/E
7.76
Price / Sales
1.04
Enterprise Value
$1.05 B
EV / EBITDA
10.75
EV / Revenue
0.82
Rating
None
Target Price
$27.45
EPS Forecast (FY)
—
Pros
- Efficient use of capital employed.
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
Cons
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Humana Inc. | $216 | 21.97 | $26.04 B | 1.68% | — | 7.04% | $315.35 / $163.11 | $146.42 |
| 2. | UnitedHealth Group Incorporated | $354.97 | 26.8 | $323.02 B | 2.73% | 9.74% | 12.54% | $489.79 / $234.6 | $103.87 |
| 3. | Centene Corporation | $39.26 | — | $19.34 B | — | -0.78% | -28.68% | $64.15 / $25.08 | $40.58 |
| 4. | Clover Health Investments, Corp. | $2.23 | — | $1.15 B | — | -25.75% | -26.33% | $3.92 / $1.58 | $0.59 |
| 5. | CVS Health Corporation | $77.63 | 55.78 | $99.22 B | 3.47% | 6.3% | 2.29% | $85.15 / $58.35 | $59.18 |
| 6. | The Cigna Group | $279.79 | 12.61 | $73.76 B | 2.24% | — | 15.13% | $350 / $239.51 | $158.32 |
| 7. | Alignment Healthcare, Inc. | $21.56 | — | $4.34 B | — | 2.9% | -0.7% | $23.87 / $11.62 | $0.88 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | |
|---|---|---|---|---|---|
| Sales | 318.4 M | 313.35 M | 332.87 M | 324.04 M | 298.43 M |
| Operating Profit | 15.22 M | 21.53 M | 24.36 M | 24.17 M | 15.79 M |
| Net Profit | 12.48 M | 13.86 M | 17.11 M | 15.06 M | 10.53 M |
| EPS in Rs | 0.15 | 0.17 | 0.21 | 0.18 | 0.13 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 1.29 B | 1.17 B | 1.09 B | 786.91 M |
| Operating Profit | 85.28 M | 67.45 M | 62.18 M | 23.34 M |
| Net Profit | 58.52 M | 54.34 M | 62.04 M | 30.36 M |
| EPS in Rs | 0.71 | 0.66 | 0.76 | 0.37 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 742.43 M | 607.1 M | 756.62 M | 542.99 M |
| Total Liabilities | 226.39 M | 185.04 M | 203.19 M | 166.02 M |
| Equity | 516.04 M | 422.06 M | 553.43 M | 376.97 M |
| Current Assets | 551.77 M | 472.72 M | 640.41 M | 433.86 M |
| Current Liabilities | 202.39 M | 168.63 M | 185.95 M | 159.54 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 210.19 M | 179.1 M | 188.81 M | 80.39 M |
| Investing CF | -159.01 M | 195.79 M | -200.53 M | -43.87 M |
| Financing CF | -99.36 M | -309.88 M | -11.07 M | -7.86 M |
| Free CF | 191.78 M | 173.7 M | 185.17 M | 77.15 M |
| Capex | -18.41 M | -5.41 M | -3.64 M | -3.24 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 7.22% | 38.34% | — | — |
| Earnings Growth % | -12.41% | 104.35% | — | — |
| Profit Margin % | 4.66% | 5.7% | 3.86% | — |
| Operating Margin % | 5.78% | 5.71% | 2.97% | — |
| Gross Margin % | 21.71% | 21.94% | 21.26% | — |
| EBITDA Margin % | 6.05% | 5.92% | 3.17% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.